Review

Cellular and Molecular Life Sciences CMLS

, Volume 62, Issue 2, pp 119-127

Protein kinase C regulation of GABAA receptors

  • M. SongAffiliated withErnest Gallo Clinic and Research Center, Department of Neurology, Graduate Program in Neuroscience, University of California
  • , R. O. MessingAffiliated withErnest Gallo Clinic and Research Center, Department of Neurology, Graduate Program in Neuroscience, University of California Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract.

Pharmacological studies with drugs that activate or inhibit several protein kinase C (PKC) isozymes have identified the PKC family of serine-threonine kinases as important in the regulation of γ-aminobutyric acid type A (GABAA) receptor function. PKC modulates GABAA receptor surface density, chloride conductance and receptor sensitivity to positive allosteric modulators such as neurosteroids, ethanol, benzodiazepines and barbiturates. Recent studies using PKC isozyme-selective reagents and gene-targeted mice have begun to identify critical roles for three isozymes, PKCβII, PKCɛ and PKCγ, in various aspects of GABAA receptor regulation. Progress in this field touches upon therapeutic areas that are of great clinical importance such as anxiety and addiction. Increased understanding of how PKC regulates GABAA receptors and which PKC isozymes are involved holds promise for development of new treatments for diverse neuropsychiatric disorders.

Key words.

Protein kinase C gamma-aminobutyric acid neurosteroid ethanol phosphorylation receptor for activated C kinase phorbol ester